FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
9 clinical trials · Condition
◉ Watch FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer (NCT04092270) | National Cancer Institute (NCI) | 2020-05-07 |
| Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer (NCT03300557) | National Cancer Institute (NCI) | 2017-11-15 |
| Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer (NCT03018249) | National Cancer Institute (NCI) | 2017-10-11 |
| Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer (NCT02397083) | M.D. Anderson Cancer Center | 2015-09-23 |
| Prediction of Recurrence Among Low Risk Endometrial Cancer Patients (NCT04604613) | M.D. Anderson Cancer Center | 2012-11-08 |
Track FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.